{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:18:30Z","timestamp":1778156310010,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MNESYS (PE0000006)"],"award-info":[{"award-number":["MNESYS (PE0000006)"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01434-8","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:45:56Z","timestamp":1771274756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nusinersen rescues taurine deficiency in patients with type 1 Spinal Muscular Atrophy"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-3517","authenticated-orcid":false,"given":"Raffaella","family":"di Vito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-8304","authenticated-orcid":false,"given":"Anna","family":"Caretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9276-4590","authenticated-orcid":false,"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-2128","authenticated-orcid":false,"given":"Alessandro","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1211-1552","authenticated-orcid":false,"given":"Marina","family":"Boido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-7395","authenticated-orcid":false,"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-5628","authenticated-orcid":false,"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9203-853X","authenticated-orcid":false,"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"1434_CR2","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"S Tisdale","year":"2015","unstructured":"Tisdale, S. & Pellizzoni, L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J. Neurosci. Off. J. Soc. Neurosci. 35, 8691\u20138700 (2015).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"1434_CR3","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. USA. 96, 6307\u20136311 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1434_CR4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani, U. R. et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177\u20131183 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"1434_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth, B. Spinal muscular atrophy: in the challenge lies a solution. Trends Neurosci 44, 306\u2013322 (2021).","journal-title":"Trends Neurosci"},{"key":"1434_CR6","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn, M. R. & Wang, C. H. Spinal muscular atrophy. The Lancet 371, 2120\u20132133 (2008).","journal-title":"The Lancet"},{"key":"1434_CR7","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.xcrm.2021.100346","volume":"2","author":"H Chaytow","year":"2021","unstructured":"Chaytow, H., Faller, K. M. E., Huang, Y.-T. & Gillingwater, T. H. Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine. Cell Rep. Med. 2, 100346 (2021).","journal-title":"Cell Rep. Med."},{"key":"1434_CR8","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200374","volume":"15","author":"MK Schroth","year":"2025","unstructured":"Schroth, M. K. et al. Spinal muscular atrophy update in best practices: recommendations for treatment considerations. Neurol. Clin. Pract. 15, e200374 (2025).","journal-title":"Neurol. Clin. Pract."},{"key":"1434_CR9","doi-asserted-by":"publisher","first-page":"592234","DOI":"10.3389\/fphar.2020.592234","volume":"11","author":"G Menduti","year":"2020","unstructured":"Menduti, G., Ras\u00e0, D. M., Stanga, S. & Boido, M. Drug screening and drug repositioning as promising therapeutic approaches for spinal muscular atrophy treatment. Front. Pharmacol. 11, 592234 (2020).","journal-title":"Front. Pharmacol."},{"key":"1434_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nn.4561","volume":"20","author":"EV Fletcher","year":"2017","unstructured":"Fletcher, E. V. et al. Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. Nat. Neurosci. 20, 905\u2013916 (2017).","journal-title":"Nat. Neurosci."},{"key":"1434_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","volume":"69","author":"GZ Mentis","year":"2011","unstructured":"Mentis, G. Z. et al. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron 69, 453\u2013467 (2011).","journal-title":"Neuron"},{"key":"1434_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015457","volume":"5","author":"KKY Ling","year":"2010","unstructured":"Ling, K. K. Y., Lin, M.-Y., Zingg, B., Feng, Z. & Ko, C.-P. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PloS One 5, e15457 (2010).","journal-title":"PloS One"},{"key":"1434_CR13","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1016\/j.celrep.2019.11.058","volume":"29","author":"CM Simon","year":"2019","unstructured":"Simon, C. M. et al. Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy. Cell Rep 29, 3885\u20133901.e5 (2019).","journal-title":"Cell Rep"},{"key":"1434_CR14","doi-asserted-by":"crossref","unstructured":"Buettner, J. M. et al. Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models. iScience 24, 103376 (2021).","DOI":"10.1016\/j.isci.2021.103376"},{"key":"1434_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fncel.2019.00015","volume":"13","author":"J Sun","year":"2019","unstructured":"Sun, J. & Harrington, M. A. The alteration of intrinsic excitability and synaptic transmission in lumbar spinal motor neurons and interneurons of severe spinal muscular atrophy mice. Front. Cell. Neurosci. 13, 15 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"1434_CR16","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00018-021-03819-5","volume":"78","author":"R James","year":"2021","unstructured":"James, R., Chaytow, H., Ledahawsky, L. M. & Gillingwater, T. H. Revisiting the role of mitochondria in spinal muscular atrophy. Cell. Mol. Life Sci. 78, 4785\u20134804 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"1434_CR17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/biom12101431","volume":"12","author":"F Errico","year":"2022","unstructured":"Errico, F. et al. Nusinersen induces disease-severity-specific neurometabolic effects in spinal muscular atrophy. Biomolecules 12, 1431 (2022).","journal-title":"Biomolecules"},{"key":"1434_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00018-023-04885-7","volume":"80","author":"I Faravelli","year":"2023","unstructured":"Faravelli, I. et al. Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study. Cell. Mol. Life Sci. CMLS 80, 241 (2023).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"1434_CR19","doi-asserted-by":"publisher","first-page":"106849","DOI":"10.1016\/j.nbd.2025.106849","volume":"207","author":"A Hassan","year":"2025","unstructured":"Hassan, A. et al. Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy. Neurobiol. Dis. 207, 106849 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1434_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14718","volume":"30","author":"M Lu","year":"2024","unstructured":"Lu, M. et al. Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III. CNS Neurosci. Ther. 30, e14718 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"1434_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s42003-023-05543-1","volume":"6","author":"V Valsecchi","year":"2023","unstructured":"Valsecchi, V. et al. SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy. Commun. Biol. 6, 1155 (2023).","journal-title":"Commun. Biol."},{"key":"1434_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00415-025-12909-4","volume":"272","author":"M Zandl-Lang","year":"2025","unstructured":"Zandl-Lang, M. et al. Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients. J. Neurol. 272, 183 (2025).","journal-title":"J. Neurol."},{"key":"1434_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13052-024-01726-6","volume":"50","author":"W Zhuang","year":"2024","unstructured":"Zhuang, W. et al. Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study. Ital. J. Pediatr. 50, 154 (2024).","journal-title":"Ital. J. Pediatr."},{"key":"1434_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tins.2022.12.001","volume":"46","author":"JJ Collier","year":"2023","unstructured":"Collier, J. J., Ol\u00e1hov\u00e1, M., McWilliams, T. G. & Taylor, R. W. Mitochondrial signalling and homeostasis: from cell biology to neurological disease. Trends Neurosci 46, 137\u2013152 (2023).","journal-title":"Trends Neurosci"},{"key":"1434_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1423-0127-17-S1-S1","volume":"17","author":"J-Y Wu","year":"2010","unstructured":"Wu, J.-Y. & Prentice, H. Role of taurine in the central nervous system. J. Biomed. Sci. 17, S1 (2010).","journal-title":"J. Biomed. Sci."},{"key":"1434_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4062\/biomolther.2017.251","volume":"26","author":"S Schaffer","year":"2018","unstructured":"Schaffer, S. & Kim, H. W. Effects and mechanisms of taurine as a therapeutic agent. Biomol. Ther. 26, 225\u2013241 (2018).","journal-title":"Biomol. Ther."},{"key":"1434_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/B:NERE.0000010448.17740.6e","volume":"29","author":"A El Idrissi","year":"2004","unstructured":"El Idrissi, A. & Trenkner, E. Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem. Res. 29, 189\u2013197 (2004).","journal-title":"Neurochem. Res."},{"key":"1434_CR28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0387-7604(02)00103-1","volume":"24","author":"M Hayashi","year":"2002","unstructured":"Hayashi, M. et al. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy. Brain Dev 24, 770\u2013775 (2002).","journal-title":"Brain Dev"},{"key":"1434_CR29","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1093\/hmg\/ddw262","volume":"25","author":"N Miller","year":"2016","unstructured":"Miller, N., Shi, H., Zelikovich, A. S. & Ma, Y.-C. Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Hum. Mol. Genet. 25, 3395\u20133406 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1434_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/jnr.10027","volume":"66","author":"WQ Chen","year":"2001","unstructured":"Chen, W. Q. et al. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J. Neurosci. Res. 66, 612\u2013619 (2001).","journal-title":"J. Neurosci. Res."},{"key":"1434_CR31","doi-asserted-by":"crossref","unstructured":"Kilb, W. & Fukuda, A. Taurine as an Essential Neuromodulator during Perinatal Cortical Development. Front. Cell. Neurosci. 11, 103376 (2017).","DOI":"10.3389\/fncel.2017.00328"},{"key":"1434_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-4899-0117-0_41","volume":"442","author":"K Kuriyama","year":"1998","unstructured":"Kuriyama, K. & Hashimoto, T. Interrelationship between taurine and GABA. Adv. Exp. Med. Biol. 442, 329\u2013337 (1998).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1434_CR33","doi-asserted-by":"publisher","unstructured":"Roysommuti, S. & Wyss, J. M. The effects of taurine exposure on the brain and neurological disorders. in Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease 207\u2013213 https:\/\/doi.org\/10.1016\/B978-0-12-411462-3.00022-9 (Elsevier, 2015).","DOI":"10.1016\/B978-0-12-411462-3.00022-9"},{"key":"1434_CR34","doi-asserted-by":"crossref","unstructured":"Brand, A., Leibfritz, D., Hamprecht, B. & Dringen, R. Metabolism of cysteine in astroglial cells: synthesis of hypotaurine and taurine. J. Neurochem. 71, 827\u2013832 (1998).","DOI":"10.1046\/j.1471-4159.1998.71020827.x"},{"key":"1434_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/978-1-4615-0077-3_63","volume":"526","author":"A El Idrissi","year":"2003","unstructured":"El Idrissi, A. & Trenkner, E. Taurine regulates mitochondrial calcium homeostasis. Adv. Exp. Med. Biol. 526, 527\u2013536 (2003).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1434_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.bbabio.2009.01.019","volume":"1787","author":"EJ Griffiths","year":"2009","unstructured":"Griffiths, E. J. & Rutter, G. A. Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells. Biochim. Biophys. Acta 1787, 1324\u20131333 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"1434_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41423-023-01062-5","volume":"21","author":"JM Izquierdo","year":"2024","unstructured":"Izquierdo, J. M. Taurine as a possible therapy for immunosenescence and inflammaging. Cell. Mol. Immunol. 21, 3\u20135 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"1434_CR38","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.3390\/molecules26164913","volume":"26","author":"CJ Jong","year":"2021","unstructured":"Jong, C. J., Sandal, P. & Schaffer, S. W. The role of taurine in mitochondria health: more than just an antioxidant. Molecules 26, 4913 (2021).","journal-title":"Molecules"},{"key":"1434_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216814120","volume":"120","author":"M Boido","year":"2023","unstructured":"Boido, M. et al. Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. Proc. Natl. Acad. Sci. USA. 120, e2216814120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1434_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02065-z","volume":"16","author":"G Coratti","year":"2021","unstructured":"Coratti, G. et al. Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis. Orphanet J. Rare Dis. 16, 430 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"1434_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ana.25533","volume":"86","author":"M Pane","year":"2019","unstructured":"Pane, M. et al. Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data. Ann. Neurol. 86, 443\u2013451 (2019).","journal-title":"Ann. Neurol."},{"key":"1434_CR42","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1212\/WNL.0000000000006050","volume":"91","author":"M Pane","year":"2018","unstructured":"Pane, M. et al. An observational study of functional abilities in infants, children, and adults with type 1 SMA. Neurology 91, e696\u2013e703 (2018).","journal-title":"Neurology"},{"key":"1434_CR43","doi-asserted-by":"publisher","first-page":"107046","DOI":"10.1016\/j.nbd.2025.107046","volume":"214","author":"A Hassan","year":"2025","unstructured":"Hassan, A. et al. Nusinersen corrects L-arginine deficiency in the cerebrospinal fluid of patients with severe spinal muscular atrophy. Neurobiol. Dis. 214, 107046 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1434_CR44","doi-asserted-by":"publisher","unstructured":"Kuriyama, K., Ohkuma, S., Kishi, M. & Kimori, M. Development of Biosynthesizing and Uptake Systems for Taurine in Cerebral Cortical Neurons in Primary Culture: Analysis of Possible Factors Involved in Perinatal Decline of Cerebral Taurine. in The Biology of Taurine: Methods and Mechanisms (eds. Huxtable, R. J., Franconi, F. & Giotti, A.) 69\u201377 https:\/\/doi.org\/10.1007\/978-1-4899-0405-8_7 (Springer US, Boston, MA, 1987).","DOI":"10.1007\/978-1-4899-0405-8_7"},{"key":"1434_CR45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/nu14061292","volume":"14","author":"Z Rafiee","year":"2022","unstructured":"Rafiee, Z., Garc\u00eda-Serrano, A. M. & Duarte, J. M. N. Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes. Nutrients 14, 1292 (2022).","journal-title":"Nutrients"},{"key":"1434_CR46","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/hmg\/ddm367","volume":"17","author":"LM Murray","year":"2008","unstructured":"Murray, L. M. et al. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17, 949\u2013962 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1434_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-022-00305-9","volume":"12","author":"V Woschitz","year":"2022","unstructured":"Woschitz, V., Mei, I., Hedlund, E. & Murray, L. M. Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience. Skelet. Muscle 12, 22 (2022).","journal-title":"Skelet. Muscle"},{"key":"1434_CR48","doi-asserted-by":"publisher","first-page":"19348","DOI":"10.1073\/pnas.1319280110","volume":"110","author":"Z Zhang","year":"2013","unstructured":"Zhang, Z. et al. Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 110, 19348\u201319353 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1434_CR49","doi-asserted-by":"publisher","first-page":"32002","DOI":"10.1074\/jbc.M111.253344","volume":"286","author":"V Vitvitsky","year":"2011","unstructured":"Vitvitsky, V., Garg, S. K. & Banerjee, R. Taurine biosynthesis by neurons and astrocytes. J. Biol. Chem. 286, 32002\u201332010 (2011).","journal-title":"J. Biol. Chem."},{"key":"1434_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39788-w","volume":"9","author":"K Ohuchi","year":"2019","unstructured":"Ohuchi, K. et al. Notch signaling mediates astrocyte abnormality in spinal muscular atrophy model systems. Sci. Rep. 9, 3701 (2019).","journal-title":"Sci. Rep."},{"key":"1434_CR51","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/ddv148","volume":"24","author":"H Rindt","year":"2015","unstructured":"Rindt, H. et al. Astrocytes influence the severity of spinal muscular atrophy. Hum. Mol. Genet. 24, 4094\u20134102 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"1434_CR52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-023-02554-4","volume":"145","author":"L-I Schmitt","year":"2023","unstructured":"Schmitt, L.-I. et al. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy. Acta Neuropathol. (Berl.) 145, 611\u2013635 (2023).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"1434_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00726-007-0553-9","volume":"34","author":"P Saransaari","year":"2008","unstructured":"Saransaari, P. & Oja, S. S. Nitric oxide is involved in taurine release in the mouse brain stem under normal and ischemic conditions. Amino Acids 34, 429\u2013436 (2008).","journal-title":"Amino Acids"},{"key":"1434_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1023\/A:1015551914390","volume":"27","author":"P Saransaari","year":"2002","unstructured":"Saransaari, P. & Oja, S. S. Ischemia-induced taurine release is modified by nitric oxide-generating compounds in slices from the developing and adult mouse hippocampus. Neurochem. Res. 27, 395\u2013402 (2002).","journal-title":"Neurochem. Res."},{"key":"1434_CR55","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0306-4522(98)00417-5","volume":"89","author":"P Saransaari","year":"1999","unstructured":"Saransaari, P. & Oja, S. S. Taurine release modified by nitric oxide-generating compounds in the developing and adult mouse hippocampus. Neuroscience 89, 1103\u20131111 (1999).","journal-title":"Neuroscience"},{"key":"1434_CR56","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.celrep.2016.06.087","volume":"16","author":"CM Simon","year":"2016","unstructured":"Simon, C. M. et al. A stem cell model of the motor circuit uncouples motor neuron death from hyperexcitability induced by SMN deficiency. Cell Rep. 16, 1416\u20131430 (2016).","journal-title":"Cell Rep."},{"key":"1434_CR57","doi-asserted-by":"publisher","first-page":"175092","DOI":"10.1016\/j.ejphar.2022.175092","volume":"928","author":"MZ Elhussiny","year":"2022","unstructured":"Elhussiny, M. Z. et al. Intracerebroventricular injection of taurine induces hypothermia through modifying monoaminergic pathways in chicks. Eur. J. Pharmacol. 928, 175092 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"1434_CR58","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0306-4522(84)90086-1","volume":"13","author":"P Kontro","year":"1984","unstructured":"Kontro, P., Korpi, E. R., Oja, O. S. & Oja, S. S. Modulation of noradrenaline uptake and release by taurine in rat cerebral slices. Neuroscience 13, 663\u2013666 (1984).","journal-title":"Neuroscience"},{"key":"1434_CR59","doi-asserted-by":"publisher","first-page":"115147","DOI":"10.1016\/j.celrep.2024.115147","volume":"44","author":"JG Pagiazitis","year":"2025","unstructured":"Pagiazitis, J. G. et al. Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy. Cell Rep 44, 115147 (2025).","journal-title":"Cell Rep"},{"key":"1434_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13397-6","volume":"12","author":"T Nakazato","year":"2022","unstructured":"Nakazato, T. et al. Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis. Sci. Rep. 12, 9155 (2022).","journal-title":"Sci. Rep."},{"key":"1434_CR61","unstructured":"Purves, D. et al. Lower Motor Neuron Circuits and Motor Control. in Neuroscience 6th edn (Sinauer Associates, 2018)."},{"key":"1434_CR62","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1002\/wdev.363","volume":"9","author":"V Coelho-Santos","year":"2020","unstructured":"Coelho-Santos, V. & Shih, A. Y. Postnatal development of cerebrovascular structure and the neurogliovascular unit. Wiley Interdiscip. Rev. Dev. Biol. 9, e363 (2020).","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"1434_CR63","doi-asserted-by":"publisher","first-page":"122284","DOI":"10.1016\/j.lfs.2023.122284","volume":"336","author":"MM Ommati","year":"2024","unstructured":"Ommati, M. M. et al. Pre\/postnatal taurine supplementation improves neurodevelopment and brain function in mice offspring: a persistent developmental study from puberty to maturity. Life Sci 336, 122284 (2024).","journal-title":"Life Sci"},{"key":"1434_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-3782(78)90048-8","volume":"2","author":"DK Rassin","year":"1978","unstructured":"Rassin, D. K., Sturman, J. A. & Gaull, G. E. Taurine and other free amino acids in milk of man and other mammals. Early Hum. Dev. 2, 1\u201313 (1978).","journal-title":"Early Hum. Dev."},{"key":"1434_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","volume":"106","author":"BD Semple","year":"2013","unstructured":"Semple, B. D., Blomgren, K., Gimlin, K., Ferriero, D. M. & Noble-Haeusslein, L. J. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 106, 1\u201316 (2013).","journal-title":"Prog. Neurobiol."},{"key":"1434_CR66","first-page":"585","volume":"15","author":"T Kubo","year":"1993","unstructured":"Kubo, T., Amano, M., Ishizuka, T. & Ozaki, S. beta-Alanine and taurine microinjected into the rat caudal ventrolateral medulla increase blood pressure. Clin. Exp. Hypertens. N. Y. N 1993 15, 585\u2013597 (1993).","journal-title":"Clin. Exp. Hypertens. N. Y. N 1993"},{"key":"1434_CR67","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1471-4159.1989.tb09247.x","volume":"53","author":"MP Meeley","year":"1989","unstructured":"Meeley, M. P., Underwood, M. D., Talman, W. T. & Reis, D. J. Content and in vitro release of endogenous amino acids in the area of the nucleus of the solitary tract of the rat. J. Neurochem. 53, 1807\u20131817 (1989).","journal-title":"J. Neurochem."},{"key":"1434_CR68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00726-006-0375-1","volume":"32","author":"P Saransaari","year":"2007","unstructured":"Saransaari, P. & Oja, S. S. Taurine release in mouse brain stem slices under cell-damaging conditions. Amino Acids 32, 439\u2013446 (2007).","journal-title":"Amino Acids"},{"key":"1434_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.regpep.2004.12.031","volume":"129","author":"J Wang","year":"2005","unstructured":"Wang, J., Peng, Y.-J. & Zhu, D.-N. Amino acids modulate the hypotensive effect of angiotensin-(1-7) at the caudal ventrolateral medulla in rats. Regul. Pept. 129, 1\u20137 (2005).","journal-title":"Regul. Pept."},{"key":"1434_CR70","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","volume":"19","author":"CR Heier","year":"2010","unstructured":"Heier, C. R., Satta, R., Lutz, C. & DiDonato, C. J. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum. Mol. Genet. 19, 3906\u20133918 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1434_CR71","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ebiom.2018.04.024","volume":"31","author":"LM Walter","year":"2018","unstructured":"Walter, L. M. et al. Interventions targeting glucocorticoid-Kr\u00fcppel-like factor 15-branched-chain amino acid signaling improve disease phenotypes in spinal muscular atrophy mice. EBioMedicine 31, 226\u2013242 (2018).","journal-title":"EBioMedicine"},{"key":"1434_CR72","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to taurine and \u201cimmune system protection\u201d (ID 611), \u201cmetabolism processes\u201d (ID 613), contribution to normal cognitive function (ID 1659), maintenance of normal cardiac function (ID 1661), maintenance of normal muscle function (ID 1949) and delay in the onset of physical fatigue during exercise (ID 1958) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA J. 9, 2035 (2011).","DOI":"10.2903\/j.efsa.2011.2035"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01434-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:03:04Z","timestamp":1778155384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01434-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01434-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6566128\/v1","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.B. received advisory board honoraria from Roche, Biogen, PTC, Red Nucleus. None of these founders had a role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}